Crossmark

Rosuvastatin Flexible Chitosomes: Development, In Vitro Evaluation and Enhancement of Anticancer Efficacy Against HepG2 and MCF7 Cell Lines

Crossref DOI link: https://doi.org/10.1208/s12249-024-02957-w

Published Online: 2024-10-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Eleraky, Nermin E. https://orcid.org/0000-0001-5218-4575
Hassan, Abeer S. https://orcid.org/0000-0001-8984-2957
Soliman, Ghareb M. https://orcid.org/0000-0002-9674-1254
Al-Gayyar, Mohammed M. H. https://orcid.org/0000-0003-4777-3919
Safwat, Mohamed A. https://orcid.org/0000-0002-0512-7479
License Information

Text and Data Mining valid from 2024-10-07

Version of Record valid from 2024-10-07
More Information

Article History

Received: 16 July 2024

Accepted: 23 September 2024

First Online: 7 October 2024

Declarations

:

: The authors report there are no competing interests to declare.